Analyst Moves: ENDP, PRU, AZO - Presented by: The Aol. On Network

This morning, UBS reduced its price target on shares of Endo Health Solutions (ENDP) to $39 per share following an unfavorable FDA ruling last week. In the report, UBS slashed its EPS estimates as well.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
F $ 13.80 0.60 ▼ 4.17%
PBR $ 12.78 0.67 ▲ 5.53%
MSFT $ 45.975 0.96 ▲ 2.12%
PBR/A $ 13.25 0.89 ▲ 7.20%
AAPL $ 105.01 0.18 ▲ 0.17%
VALE $ 11.2341 0.40 ▲ 3.73%
BAC $ 16.67 0.07 ▲ 0.42%
P $ 19.95 3.17 ▼ 13.71%

As of 10/24/2014, 03:03 PM
More Most Active